NDC 50742-283 – Bismuth subcitrate potassium, Metronidazole, Tetracycline hydrochloride

Bismuth Subcitrate Potassium 140 mg/1; Metronidazole 125 mg/1; Tetracycline Hydrochloride 125 mg/1 · Capsule · Oral

Human Prescription Drug

Product NDC50742-283

Product details

Brand name
Bismuth subcitrate potassium, Metronidazole, Tetracycline hydrochloride
Generic name
Bismuth subcitrate potassium, Metronidazole, Tetracycline hydrochloride
Labeler
Ingenus Pharmaceuticals, LLC
Dosage form
Capsule
Route
Oral
Marketing category
ANDA · ANDA217511
Marketed since
July 4, 2023
Listing expires
December 31, 2026
Pharmacologic class
Bismuth; Nitroimidazole Antimicrobial; Tetracycline-class Antimicrobial

Active ingredients

Uses, dosage, side effects and warnings for Bismuth subcitrate potassium, Metronidazole, Tetracycline hydrochloride →

Package NDC codes (1)

Package NDCDescriptionSince
50742-283-13120 CAPSULE in 1 CARTON (50742-283-13)Jul 4, 2023